The 16th Annual Summit is coming to Washington, DC on November 14-15, 2022. More details coming soon.


Identifying and Advancing Novel Pain Drugs Through Clinical Development and Commercialization

2017 Speaking Faculty


Conference Chair

William Schmidt, Ph.D.

Northstar Consulting


Speaking Faculty

  • Laura Bohn, Ph.D.

  • Professor, Departments of Molecular Medicine & Neuroscience
  • The Scripps Research Institute

  • Nigel Calcutt, Ph.D.

  • Professor, University of California, San Diego
  • Co-Founder, WinSanTor

  • Allen Downs, CLP

  • Senior Corporate & Business Development Lead, Corporate & Business Development
  • Mundipharma International Limited

  • Andre Ghetti, Ph.D.

  • Chief Executive Officer
  • AnaBios Corporation

  • Narender Gavva, Ph.D.

  • Scientific Director
  • Amgen

  • Geert Jan Groeneveld, MD, Ph.D.

  • Research Director, CNS
  • Centre for Human Drug Research

  • Tilo Grosser, MD

  • Research Associate Professor, Department of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine
  • University of Pennsylvania

  • Mary Hannaman, MD

  • President, Co-Founder
  • NeuroDigm

  • Sunyoung Kim, D.Phil.

  • Founder and Chief Scientific Officer
  • Viromed

  • D. Lynn Kirkpatrick, Ph.D.

  • President and CEO
  • Ensysce Biosciences

  • Sanford J. Madigan, Ph.D.

  • Chief Executive Officer
  • Sova Pharmaceuticals

  • Aashish Manglik, MD, Ph.D.

  • Stanford Distinguished Fellow, Department of Molecular and Cellular Physiology
  • Stanford University School of Medicine

  • Daniel Mikol, MD, Ph.D.

  • Executive Medical Director, Global Neuroscience Development
  • Amgen

  • Mikhail "Mike" Nemenov, Ph.D.

  • Founder and Chief Scientist, LasMed LLC
  • Senior Research Scholar, Stanford University

  • Frank Rice, Ph.D.

  • President and Chief Scientist
  • Integrated Tissue Dynamics

  • Neil Singla, MD

  • Chief Scientific Officer
  • Lotus Clinical Research


  • Randall Stevens, MD

  • Chief Medical Officer
  • Centrexion Therapeutics

  • Simon Tate, Ph.D.

  • Chief Scientific Officer, Convergence Pharmaceuticals
  • Non-Executive Director, Biogen

  • Tanya Wallace, Ph.D.

  • Head of Biology
  • Blackthorn Therapeutics

  • Eric Nisenbaum, Ph.D.

  • Group Leader Neurophysiology, Neuroscience Division
  • Eli Lilly and Company

Organized and Produced by


Join our Social Media Groups

Pain Drug Development Group

Conference Twitter Feed

About Us

Arrowhead Publishers' conferences offer more than simply presentations; we offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward. 

Contact Us

For general information about the conference, please contact us at:
 This email address is being protected from spambots. You need JavaScript enabled to view it.
  PO Box 96, Chanhassen, MN 55317 USA